← All companies
ALNYLAM PHARMACEUTICALS, INC.
ALNY - Company ID 0001178670
Market cap$20.89 B
Rank#601
Filings1,651
The table below shows ALNYLAM PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.75B | $1.71B | $1.49B | $1.11B | $1.02B | $1.10B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.08B | $912.74M | $964.77M | $567.11M | $418.04M | $353.85M |
| Inventory | $105.91M | $97.11M | $75.38M | $71.69M | $65.58M | $75.99M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.